Careers

Insight

Collectively, the Principals at Monument Analytics have worked with hundreds of clients and products since the 1980s. As we reflect on this experience, we realize that healthcare consultants often fall into one of two categories. Typical “boutique” consulting companies may well understand clients’ business needs, but often have fewer resources devoted to, and less experience in, creative research designs and rigorous analytics. Independent consultants from other sectors may have strong technical skills, but fail to understand the commercial needs of their clients. At Monument Analytics, we package top notch scientific acumen in a commercial vehicle based on the strategic needs of our clients.

Personalized Service with Extensive Reach

As a boutique consulting firm, we offer clients customized solutions, one client at a time. Our team leaders bring years of life science industry experience as we work closely and collaboratively with clients throughout the project lifecycle, avoiding the inflexibility and inefficiencies that all too often beset larger commercial organizations. At the same time, we are able to access world-class health care and medical scientists covering literally every public health area and clinical specialty. This combination of experiences, skills and resources give us a unique platform from which to understand and address our clients’ needs.

A Focus on Value

At Monument Analytics, we are focused on determining, demonstrating, communicating and helping realize value for our clients. Value in the life sciences is multi-dimensional, ranging from understanding and quantitatively characterizing burden of illness, to designing effective clinico-economic studies of medical interventions and technologies to test the validity of value propositions, ultimately to fielding post-marketing evaluations of the “real-world” impact of these treatments on disease burden, quality-of-life, resource use, and costs.

News

Addressing Value Defects From Wasteful Services Through Health Technology Assessment

Addressing Value Defects From Wasteful Services Through Health Technology Assessment

Stage Analytics colleagues Bill Padula, Brett McQueen and Natalie Reid published an article in Health Affairs Forefront outlining how to reduce U.S. healthcare costs by leveraging available evidence to phase-out value defects.
Bedsores kill over 60K people in the US each year. Amid COVID, experts worry more may be at risk.

Bedsores kill over 60K people in the US each year. Amid COVID, experts worry more may be at risk.

Stage Analytics Principal Dr. Bill Padula was cited in a USA Today article exploring concerns that rates of pressure ulcer injury may escalate amidst the COVID-19 pandemic.
Higher Health Care Value Post COVID-19

Higher Health Care Value Post COVID-19

Stage Analytics Principal Dr. Bill Padula wrote a Health Affairs Blog exploring how economic evaluation methods can be used to determine the value and price of disruptive health technologies in a post-Covid-19 world.
Global budgets offer financial cushion amid the coronavirus pandemic

Global budgets offer financial cushion amid the coronavirus pandemic

Stage Analytics Principal Dr. William Padula co-authored an article in Modern Healthcare on global budgets during the Covid-19 pandemic.
Health Technology Assessment in the U.S. – A Vision for the Future

Health Technology Assessment in the U.S. – A Vision for the Future

Stage Analytics Principal Dr. Bill Padula co-authored a white paper which made a series of recommendations on Health Technology Assessments (HTA) in the United States.
The Justice Department accuses Walmart of fuelling the opioid crisis

The Justice Department accuses Walmart of fuelling the opioid crisis

Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was prominently quoted discussing the U.S. opioid epidemic in an article in The Economist examining the role of pharmacies in contributing to harms.
NPIAP Board of Directors

NPIAP Board of Directors

Stage Analytics Principal Dr. Bill Padula was elected 2021 President of the National Pressure Injury Advisory Panel.
Heralded Alzheimer’s drug works — but safety concerns loom

Heralded Alzheimer’s drug works — but safety concerns loom

Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in Nature examining the FDA's possible approval of an experimental Alzheimer's drug.
Biden Administration Offers Plan to Get Addiction-Fighting Medicine to Pregnant Women

Biden Administration Offers Plan to Get Addiction-Fighting Medicine to Pregnant Women

Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in The New York Times regarding the expansion of treatments for substance use disorders among pregnant women.
FDA panel backs much-debated ALS drug in rare, 2nd review

FDA panel backs much-debated ALS drug in rare, 2nd review

Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an AP News article examining the approval of a new drug to treat ALS.
US hospitals are safer for patients than a decade ago, but more work remains: study

US hospitals are safer for patients than a decade ago, but more work remains: study

Stage Analytics Principal Dr. Bill Padula's scholarship was discussed in a Changing America article about adverse events in hospitals and health systems.
CLICK HERE TO SEE ALL
Stage Analytics
Stage Analytics

Get industry insights and Stage Analytics news in your inbox!

Sign up for our monthly email newsletter.

Skip to content